Wegovy dosage

Injection schedule

Every schedule on this page is reported from the FDA label of the approved products, as background, and is not dosing advice for any reader. The prescriber applies it to each patient, sets every step and can slow the climb.¹ The label uses the same 16-week climb for every approved use of the injection.¹ Each step lasts 4 weeks, and the slow increase is meant to reduce stomach and bowel side effects.¹

If a step is not tolerated, the label says to consider delaying the next increase for 4 weeks.¹ The weekly dose falls on the same weekday, and neither the time of day nor meals matter.¹

Maintenance dose by approved use

The 7.2 mg step, approved on March 19, 2026, is the Wegovy HD dose.⁵ Approved injected semaglutide doses run from 0.25 mg to 7.2 mg once weekly, so this is the top of that range.¹⁶

Tablet schedule

Wegovy tablets are approved for adults, for weight reduction and cardiovascular risk reduction.²¹

Only about 1% to 2% of an oral dose is absorbed, against 89% of an injection, so the daily tablet dose is far larger than the weekly injected dose.⁶¹ If 25 mg is not tolerated, the label suggests considering a switch to the 1.7 mg weekly injection.¹

Missed doses

• Injection, next dose more than 2 days (48 hours) away. The missed dose is taken as soon as possible.¹
• Injection, next dose less than 2 days away. The missed dose is skipped, and the next one is taken on the usual day.¹
• Two or more weekly doses missed in a row. The label says to restart dose escalation at a lower dose, to reduce stomach side effects.¹ The Medication Guide tells patients to contact their healthcare provider about restarting.¹
• Tablet. The missed tablet is skipped and the next one is taken the following day, never more than one tablet a day.¹

Switching forms and changing the day

People on the 2.4 mg injection may start 25 mg tablets one week after their last injection.¹ People on 25 mg tablets may start the 2.4 mg injection the day after their last tablet.¹ The weekly injection day can be changed as long as the last dose was given 2 or more days before.¹

Which product gives which dose

Each single-dose pen or syringe holds one preset weekly dose, from 0.25 mg to 2.4 mg, or 7.2 mg in the Wegovy HD pen.¹ The FlexTouch pen can only be dialed to 2.4 mg and gives four weekly doses.¹ Presentations and pen handling are covered in Wegovy injection sites and pen use.

Overdose and combined use

Overdose effects reported with GLP-1 drugs include severe nausea, severe vomiting and severe low blood sugar.¹ Because semaglutide's half-life is about 1 week, observation and treatment may need to last a long time.¹ After an overdose, the label suggests contacting the Poison Help line or a medical toxicologist.¹ The label does not recommend using Wegovy with other semaglutide products or any other GLP-1 receptor agonist.¹

Doses outside the label

The schedules above are the label's, for FDA-approved Wegovy pens, syringes and tablets.¹ FDA says compounded GLP-1 drugs are not FDA approved, and that unapproved versions, including products labeled for research use, do not go through FDA review for safety, effectiveness or quality.⁷ Most dosing-error reports FDA described for compounded semaglutide involved patients drawing too much from a multiple-dose vial, taking 5 to 20 times the intended dose.⁸ FDA said confusion between milliliters, milligrams and syringe "units" may have contributed.⁸

Related pages

Back to the Wegovy profile. Side effects at each dose level are listed in Wegovy side effects. Trial results for each dose are in Wegovy benefits and uses. The diabetes brand's own schedule is in Ozempic dosage.